NOVEL COMPOUNDS THAT ARE ERK INHIBITORS
Disclosed are the ERK inhibitors of formula (1.0), having a pyrazolopyridine base structure, and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1.0).
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TANG, Shuyi LIPFORD, Kathryn BOYCE, Christopher RICHARD, Judson, E KARUNAKARAN, Ganesh Babu DANIELS, Matthew, H KOZLOWSKI, Joseph FERGUSON, Ron SILIPHAIVANH, Phieng WILSON, Kevin, J ANGELES, Angie, R HUANG, Xianhai FEVRIER, Salem ZHOU, Wei SLOMAN, David WHITE, Catherine FALCONE, Danielle BAKSHI, Raman Kumar WITTER, David, J O'BOYLE, Brendan KURUKULASURIYA, Ravi MANSOOR, Umar Faruk |
| description | Disclosed are the ERK inhibitors of formula (1.0), having a pyrazolopyridine base structure, and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1.0). |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP2900223B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP2900223B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP2900223B13</originalsourceid><addsrcrecordid>eNrjZFD38w9z9VFw9vcN8A_1cwlWCPFwDFFwDHJVcA3yVvD08_B08gzxDwrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgFGlgYGRkbGTobGRCgBAKC2I14</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>NOVEL COMPOUNDS THAT ARE ERK INHIBITORS</title><source>esp@cenet</source><creator>TANG, Shuyi ; LIPFORD, Kathryn ; BOYCE, Christopher ; RICHARD, Judson, E ; KARUNAKARAN, Ganesh Babu ; DANIELS, Matthew, H ; KOZLOWSKI, Joseph ; FERGUSON, Ron ; SILIPHAIVANH, Phieng ; WILSON, Kevin, J ; ANGELES, Angie, R ; HUANG, Xianhai ; FEVRIER, Salem ; ZHOU, Wei ; SLOMAN, David ; WHITE, Catherine ; FALCONE, Danielle ; BAKSHI, Raman Kumar ; WITTER, David, J ; O'BOYLE, Brendan ; KURUKULASURIYA, Ravi ; MANSOOR, Umar Faruk</creator><creatorcontrib>TANG, Shuyi ; LIPFORD, Kathryn ; BOYCE, Christopher ; RICHARD, Judson, E ; KARUNAKARAN, Ganesh Babu ; DANIELS, Matthew, H ; KOZLOWSKI, Joseph ; FERGUSON, Ron ; SILIPHAIVANH, Phieng ; WILSON, Kevin, J ; ANGELES, Angie, R ; HUANG, Xianhai ; FEVRIER, Salem ; ZHOU, Wei ; SLOMAN, David ; WHITE, Catherine ; FALCONE, Danielle ; BAKSHI, Raman Kumar ; WITTER, David, J ; O'BOYLE, Brendan ; KURUKULASURIYA, Ravi ; MANSOOR, Umar Faruk</creatorcontrib><description>Disclosed are the ERK inhibitors of formula (1.0), having a pyrazolopyridine base structure, and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1.0).</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171025&DB=EPODOC&CC=EP&NR=2900223B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20171025&DB=EPODOC&CC=EP&NR=2900223B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TANG, Shuyi</creatorcontrib><creatorcontrib>LIPFORD, Kathryn</creatorcontrib><creatorcontrib>BOYCE, Christopher</creatorcontrib><creatorcontrib>RICHARD, Judson, E</creatorcontrib><creatorcontrib>KARUNAKARAN, Ganesh Babu</creatorcontrib><creatorcontrib>DANIELS, Matthew, H</creatorcontrib><creatorcontrib>KOZLOWSKI, Joseph</creatorcontrib><creatorcontrib>FERGUSON, Ron</creatorcontrib><creatorcontrib>SILIPHAIVANH, Phieng</creatorcontrib><creatorcontrib>WILSON, Kevin, J</creatorcontrib><creatorcontrib>ANGELES, Angie, R</creatorcontrib><creatorcontrib>HUANG, Xianhai</creatorcontrib><creatorcontrib>FEVRIER, Salem</creatorcontrib><creatorcontrib>ZHOU, Wei</creatorcontrib><creatorcontrib>SLOMAN, David</creatorcontrib><creatorcontrib>WHITE, Catherine</creatorcontrib><creatorcontrib>FALCONE, Danielle</creatorcontrib><creatorcontrib>BAKSHI, Raman Kumar</creatorcontrib><creatorcontrib>WITTER, David, J</creatorcontrib><creatorcontrib>O'BOYLE, Brendan</creatorcontrib><creatorcontrib>KURUKULASURIYA, Ravi</creatorcontrib><creatorcontrib>MANSOOR, Umar Faruk</creatorcontrib><title>NOVEL COMPOUNDS THAT ARE ERK INHIBITORS</title><description>Disclosed are the ERK inhibitors of formula (1.0), having a pyrazolopyridine base structure, and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1.0).</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFD38w9z9VFw9vcN8A_1cwlWCPFwDFFwDHJVcA3yVvD08_B08gzxDwrmYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgFGlgYGRkbGTobGRCgBAKC2I14</recordid><startdate>20171025</startdate><enddate>20171025</enddate><creator>TANG, Shuyi</creator><creator>LIPFORD, Kathryn</creator><creator>BOYCE, Christopher</creator><creator>RICHARD, Judson, E</creator><creator>KARUNAKARAN, Ganesh Babu</creator><creator>DANIELS, Matthew, H</creator><creator>KOZLOWSKI, Joseph</creator><creator>FERGUSON, Ron</creator><creator>SILIPHAIVANH, Phieng</creator><creator>WILSON, Kevin, J</creator><creator>ANGELES, Angie, R</creator><creator>HUANG, Xianhai</creator><creator>FEVRIER, Salem</creator><creator>ZHOU, Wei</creator><creator>SLOMAN, David</creator><creator>WHITE, Catherine</creator><creator>FALCONE, Danielle</creator><creator>BAKSHI, Raman Kumar</creator><creator>WITTER, David, J</creator><creator>O'BOYLE, Brendan</creator><creator>KURUKULASURIYA, Ravi</creator><creator>MANSOOR, Umar Faruk</creator><scope>EVB</scope></search><sort><creationdate>20171025</creationdate><title>NOVEL COMPOUNDS THAT ARE ERK INHIBITORS</title><author>TANG, Shuyi ; LIPFORD, Kathryn ; BOYCE, Christopher ; RICHARD, Judson, E ; KARUNAKARAN, Ganesh Babu ; DANIELS, Matthew, H ; KOZLOWSKI, Joseph ; FERGUSON, Ron ; SILIPHAIVANH, Phieng ; WILSON, Kevin, J ; ANGELES, Angie, R ; HUANG, Xianhai ; FEVRIER, Salem ; ZHOU, Wei ; SLOMAN, David ; WHITE, Catherine ; FALCONE, Danielle ; BAKSHI, Raman Kumar ; WITTER, David, J ; O'BOYLE, Brendan ; KURUKULASURIYA, Ravi ; MANSOOR, Umar Faruk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP2900223B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TANG, Shuyi</creatorcontrib><creatorcontrib>LIPFORD, Kathryn</creatorcontrib><creatorcontrib>BOYCE, Christopher</creatorcontrib><creatorcontrib>RICHARD, Judson, E</creatorcontrib><creatorcontrib>KARUNAKARAN, Ganesh Babu</creatorcontrib><creatorcontrib>DANIELS, Matthew, H</creatorcontrib><creatorcontrib>KOZLOWSKI, Joseph</creatorcontrib><creatorcontrib>FERGUSON, Ron</creatorcontrib><creatorcontrib>SILIPHAIVANH, Phieng</creatorcontrib><creatorcontrib>WILSON, Kevin, J</creatorcontrib><creatorcontrib>ANGELES, Angie, R</creatorcontrib><creatorcontrib>HUANG, Xianhai</creatorcontrib><creatorcontrib>FEVRIER, Salem</creatorcontrib><creatorcontrib>ZHOU, Wei</creatorcontrib><creatorcontrib>SLOMAN, David</creatorcontrib><creatorcontrib>WHITE, Catherine</creatorcontrib><creatorcontrib>FALCONE, Danielle</creatorcontrib><creatorcontrib>BAKSHI, Raman Kumar</creatorcontrib><creatorcontrib>WITTER, David, J</creatorcontrib><creatorcontrib>O'BOYLE, Brendan</creatorcontrib><creatorcontrib>KURUKULASURIYA, Ravi</creatorcontrib><creatorcontrib>MANSOOR, Umar Faruk</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TANG, Shuyi</au><au>LIPFORD, Kathryn</au><au>BOYCE, Christopher</au><au>RICHARD, Judson, E</au><au>KARUNAKARAN, Ganesh Babu</au><au>DANIELS, Matthew, H</au><au>KOZLOWSKI, Joseph</au><au>FERGUSON, Ron</au><au>SILIPHAIVANH, Phieng</au><au>WILSON, Kevin, J</au><au>ANGELES, Angie, R</au><au>HUANG, Xianhai</au><au>FEVRIER, Salem</au><au>ZHOU, Wei</au><au>SLOMAN, David</au><au>WHITE, Catherine</au><au>FALCONE, Danielle</au><au>BAKSHI, Raman Kumar</au><au>WITTER, David, J</au><au>O'BOYLE, Brendan</au><au>KURUKULASURIYA, Ravi</au><au>MANSOOR, Umar Faruk</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>NOVEL COMPOUNDS THAT ARE ERK INHIBITORS</title><date>2017-10-25</date><risdate>2017</risdate><abstract>Disclosed are the ERK inhibitors of formula (1.0), having a pyrazolopyridine base structure, and the pharmaceutically acceptable salts thereof. Also disclosed are methods of treating cancer using the compounds of formula (1.0).</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP2900223B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | NOVEL COMPOUNDS THAT ARE ERK INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T02%3A58%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TANG,%20Shuyi&rft.date=2017-10-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP2900223B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |